Synonym name: Araliasaponin V; Congmuyanoside V
Catalogue No.: BP0386
Cas No.: 340963-86-2
Formula: C₅₄H₈₈O₂₃
Mol Weight: 1105.28
Botanical Source: Aralia elata (Japanese angelica tree)

Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle
Can be supplied from milligrams to grams.

For Reference Standard and R&D, Not for Human Use Directly.
Inquire for bulk scale.

HPLC of Congmunoside V

Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Congmunoside V is a type of wood saponin V derived from Corydalis heterocarpa) has attracted widespread attention in recent years due to its potential activity in the field of anti-tumor treatment. As one of the malignant tumors with the highest incidence and mortality rates worldwide, lung cancer urgently needs new, effective, and low-toxicity treatments. Natural products, due to their structural diversity and rich biological activity, have become important resources for the development of anti-cancer drugs. Liaodong Cinnamon saponin V, with its unique chemical structure and multi-target mechanism, has demonstrated significant inhibitory effects on lung cancer cells, making it a hot topic in pharmacological research of natural products.

This paper will systematically review the chemical structure and physicochemical properties of Liaodong Oleum saponin V, plant origin and extraction methods, pharmacological activity and mechanism of action, druggability evaluation and pharmacokinetic characteristics, and explore its clinical application prospects and development directions, providing theoretical basis and reference for subsequent related research and drug development.

Chemical structure and physicochemical properties

The molecular formula of Liaodong Ole saponin V has not been fully disclosed, but its molecular weight is 1085.3, making it a high-molecular-weight triterpene saponin compound. Its LogP value is 1.0, indicating moderate lipophilicity, which facilitates membrane penetration without excessive hydrophobicity. TPSA (Topological Surface Area) reaches as high as 399.7, indicating strong molecular surface polarity and 23 hydrogen bond acceptors, indicating the molecule contains a large number of polar groups, such as hydroxyl, carboxyl, or glycoside components. These structural features significantly affect its water solubility and ability to bind target proteins.

The structural core of Liaodong Olea saponin V is a triterpene backbone, connecting multiple glycoside units to form a complex glycosidic chain structure. This structure not only imparts good bioactivity but also influences its pharmacokinetic properties, such as low blood-brain barrier permeability and low lipid solubility. It has good chemical stability and is suitable for both in vitro and in vivo pharmacological research.

Plant Origins and Extraction Methods

Liaodong Ole Saponin V mainly comes from Liaodong Corydalis (Corydalis heterocarpa), a plant belonging to the poppy family, a traditional medicinal plant distributed in Northeast China and the Korean Peninsula. In traditional Chinese medicine, Liaodong querama is often used to promote blood circulation, remove blood stasis, relieve pain, and have anti-inflammatory effects. Its rhizomes are rich in alkaloids and saponin compounds.

The extraction of Liaodong Quera saponin V is usually carried out by the following steps:

1. Raw material preparation: Collect dried roots and stems of Liaodong querama and crush them into fine powder.
2. Preliminary extraction: Use 70%-80% ethanol or methanol for reflux extraction, usually 2-3 hours, repeating 2-3 times to ensure the active ingredient is fully extracted.
3. Concentration and separation: After concentrating the extract to a certain volume, the aqueous phase is used to separate the organic phase and remove fat-soluble impurities.
4. Column chromatography purification: Separated and purified Liaodong Azurium saponin V using silica gel columns or reversed-phase C18 column chromatography combined with gradient elution technology.
5. Identification and purity testing: Technologies such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic resonance (NMR) are used to confirm the compound's structure and purity.

This extraction method can obtain high-purity Liaodong Tara saponin V, meeting the needs of pharmacological and pharmacokinetic research.

Pharmacological activity research

Liaodong Cinnamon saponin V has demonstrated significant anti-lung cancer activity in multiple in vitro and in vivo experiments. Its main pharmacological effects include:

• Inhibition of lung cancer cell proliferation: After treatment, various lung cancer cell lines (such as A549, H1299) significantly reduce cell proliferation rates, showing dose-dependence.
• Induction of apoptosis: By activating endogenous apoptosis pathways, it promotes the expression of apoptosis-related proteins, such as CASP9 (caspase 9), upregulating and promoting programmed death of lung cancer cells.
• Inhibition of tumor cell migration and invasion: Liaodong Cinnamon saponin V can interfere with the migration and invasion abilities of tumor cells, reducing the risk of metastasis.
• Anti-inflammatory and immunomodulatory effects: By modulating inflammatory factors and immune cell activity in the tumor microenvironment, tumor growth is indirectly inhibited.

Additionally, animal model studies showed that Liaodong Turberry saponin V is well tolerated, with no significant hepatotoxicity or cardiotoxicity, no hERG channel inhibition observed, and relatively high safety.

Mechanism of action and molecular targets

The anti-lung cancer effect of Liaodong Cinnamon saponin V involves multiple signaling pathways and molecular targets, reflecting its multi-target drug characteristics:

• BCL2 family proteins (BCL2): Liaodong querama saponin V downregulates the expression of the anti-apoptotic protein BCL2, promoting cell apoptosis.
• Signal transduction and transcription activator factor 3 (STAT3): Inhibits the phosphorylation and activation of STAT3, blocking its function of promoting tumor cell proliferation and immune escape.
• Estron receptor β (ESR2): regulates ESR2 expression and influences hormone-dependent growth of tumor cells.
• Microtubule-associated protein Tau (MAPT): interferes with MAPT function, affects cytoskeletal stability, and inhibits tumor cell migration.
• Phosphatidylinositol 3-kinase γ (PIK3CG): Inhibits the PI3K/AKT signaling pathway, reducing cell viability.
• Nuclear factor κB subunit RELA (RELA): inhibits the NF-κB signaling pathway, reducing inflammatory responses and tumor cell anti-apoptotic capacity.
• Mitogen-activated protein kinase 1 (MAPK1) and MAPK8: regulate the MAPK signaling pathway, affecting the cell cycle and apoptosis.
• Peroxisome proliferator-activated receptor γ (PPARG): activates PPARG, regulating cellular metabolism and proliferation.

Through multi-target synergistic effects, Liaodong Quera saponin V effectively inhibits the proliferation, migration, and survival of lung cancer cells, demonstrating strong anti-tumor potential.

Druggability evaluation and pharmacokinetics

The druggability parameters of Liaodong Quera saponin V indicate that it has certain development potential:

• It has a relatively large molecular weight (1085.3), which may affect oral bioavailability, but it is suitable for injectable formulation development.
• The LogP is 1.0, indicating moderate lipid solubility, which facilitates membrane penetration.
• TPSA as high as 399.7 suggests strong polarity, which may limit crossing the blood-brain barrier and reduce central nervous system side effects.
• It has 23 hydrogen bond receptors, which facilitate stable binding to target proteins.
• Low blood-brain barrier permeability, reducing the risk of central nervous system toxicity.
• No significant hepatotoxicity or cardiotoxicity was observed, indicating good safety.
• HERG channel inhibition is negative, indicating high cardiac safety.
• Ames-induced mutagenic test results are unknown, and further supplementary genotoxicity assessment is needed.

Pharmacokinetics, existing research is relatively limited. Preliminary data indicate that oral absorption of Liaodong Cinnamon saponin V is poor, with a moderate half-life in vivo, mainly metabolized by the liver, and metabolite activity still requires further study. In the future, systematic pharmacokinetics and toxicology studies should be conducted to optimize delivery routes and dosage form design.

Prospects and outlooks for clinical applications

Liaodong Oleam saponin V, as a natural product with multi-target anti-lung cancer activity, demonstrates excellent pharmacological activity and safety, with high potential for clinical translation. Its multi-target mechanism helps overcome the problem of single-target drug resistance, making it suitable for combination therapy strategies in lung cancer.

Future research directions include:

• In-depth pharmacokinetics and toxicology studies to clarify its in vivo behavior and safe dosage range.
• Structural optimization and derivative design enhance oral bioavailability and targeting.
• Combination drug studies explore synergistic effects with existing chemotherapy drugs, targeted drugs, or immunotherapies.
• Preclinical animal model validation to evaluate antitumor efficacy and safety.
• Clinical trial design and implementation to promote early clinical application.

In addition, the potential of Liaodong Olea saponin V in regulating the tumor microenvironment and immune regulation is also worth further exploration to expand its indication range.

Conclusion

Liaodong Triterpene Saponin V, a natural triterpene saponin derived from traditional medicinal plants, has become a key focus in pharmacological research of natural products due to its unique chemical structure and multi-target anti-lung cancer effects. Its excellent safety profile and multipathway regulatory capability provide new ideas and candidate drugs for lung cancer treatment. Although its pharmacokinetics and clinical research are still in the early stages, as research deepens, Liaodong Cinnamon Saponin V is expected to become an important natural drug resource in lung cancer treatment, driving the clinical transformation of natural products.

In the future, by integrating modern medicinal chemistry, molecular biology, and clinical medicine into interdisciplinary research, the mechanism of action of Liaodong Cinnarium saponin V will be further revealed, its drug properties optimized, its clinical application advanced, and new treatment hope for lung cancer patients.